Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Die Pharmazie|January 31, 2009
Transrepression and transactivation potencies of inhaled glucocorticoidsN L Dirks, S Li, B Huth, et al.Clinical and Experimental Immunology|November 25, 2015
From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticalsG R Gunn, D C F Sealey, F Jamali, et al.Journal of Clinical Pharmacology|October 1, 1996
Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionateS Rohatagi, A Bye, C Falcoz, et al.Journal of Pharmacokinetics and Biopharmaceutics|November 24, 1999
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroidsB Meibohm, G Hochhaus, H Möllmann, et al.International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroidsB Meibohm, H Derendorf, H Möllmann, et al.Journal of Clinical Pharmacology|August 1, 1997
Dependency of cortisol suppression on the administration time of inhaled corticosteroidsB Meibohm, G Hochhaus, S Rohatagi, et al.Journal of Veterinary Pharmacology and Therapeutics|May 22, 2012
Evaluation of regional limb perfusion with amikacin using the saphenous, cephalic, and palmar digital veins in standing horsesG Kelmer, G C Bell, T Martin-Jimenez, et al.European Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administrationH Möllmann, M Wagner, B Meibohm, et al.Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalationH Möllmann, H Derendorf, J Barth, et al.Pharmaceutical Research|October 19, 2006
A modern view of excipient effects on bioequivalence: case study of sorbitolM-L Chen, A B Straughn, N Sadrieh, et al.Pageof 3